Associate Professor Natalie Staplin
Natalie Staplin
PhD
Senior Statistician
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Science and Epidemiology.
Natalie joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics.
Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease.
She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Recent publications
Hierarchical Composite End Points: The Future of Randomized Trials of Kidney Disease?
Journal article
Staplin N. and Judge PK., (2026), Clin J Am Soc Nephrol
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal article
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and Mortality.
Journal article
Böhm M. et al, (2026), Hypertension
Association Between 24-Hour Systolic Blood Pressure Time in Target Range and Mortality.
Journal article
Lauder L. et al, (2026), Hypertension
